article thumbnail

Post-stent chest pain, revisited

Heart Sisters

Heart patients with persistent or recurrent post-stent chest pain present “an unmet clinical need”, according to the European Journal of Cardiology.

article thumbnail

Dual-Antiplatelet Therapy After Drug-Eluting Stenting in ACS

JAMA Cardiology

This systematic review and network meta-analysis investigates the optimal duration of dual antiplatelet therapy in patients with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention with drug-eluting stents.

Stent 99
article thumbnail

HonorHealth Research Institute First in Southwest to Implant New Stroke Prevention Stent

DAIC

This new system combines a truly innovative stent design,” said Dr. Ramaiah, a former director of the Arizona Heart Hospital. “We She already has three stents in her heart and so many stents and replacement arteries in both her legs that she’s lost count. The physician who performed the procedure, Venkatesh Ramaiah, M.D.,

Stent 111
article thumbnail

Modified fenestrated/branched endovascular aortic repair with short bridging stent to treat complex aortic dissection

Frontiers in Cardiovascular Medicine

Inner or outer short bridging stents were applied to fabricate PMSG with the help of 3D-printing models intraoperatively. DiscussionThe application of short bridging stents has shown promising results in reducing endoleak rates after F/B EVAR. In aortic arch group, the average operative time was 289.2 ± 88.8 min.

Stent 59
article thumbnail

Philips launches Duo Venous Stent System for Treatment of Symptomatic Venous Outflow Obstruction

DAIC

and an investigator in the VIVID study , which contributed to the device’s FDA approval – successfully used the Duo Venous Stent System for the first time outside of a clinical trial. Duo Hybrid has a distinct integrated design that combines multiple zones of differing mechanical properties into a single stent [3].

Stent 105
article thumbnail

SMT Publishes Trial Results for Supraflex Cruz Stent

DAIC

Smits and a distinguished team of international researchers, the trial compares the performance of SMT's biodegradable-polymer sirolimus-eluting Supraflex Cruz stent with the biodegradable-polymer Ultimaster Tansei * stent in patients with high bleeding risk (HBR) undergoing abbreviated dual antiplatelet therapy (DAPT).

Stent 52
article thumbnail

Resorbable stent vs. angioplasty safety outcomes: 5 study notes

Becker's Hospital Review - Cardiology

A drug-eluting resorbable stent was found to be just as effective in treating infrapopliteal artery disease in patients at risk of limb amputation, according to a study published Oct. 25 in the New England Journal of Medicine.

Stent 52